Management of Elevated WBC in Cervical Cancer

Initial Workup and Assessment

Obtain a complete blood count with differential and peripheral blood smear to characterize the leukocytosis pattern, as recommended by the National Comprehensive Cancer Network, to assess for left shift, blast cells, immature forms, or toxic granulations, and to evaluate all three cell lines, according to the Journal of the National Comprehensive Cancer Network : JNCCN 1, 2
Assess for left shift, which increases likelihood of bacterial infection, and examine for blast cells, immature forms, or toxic granulations that would suggest acute leukemia, as suggested by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 3
Evaluate all three cell lines—concurrent anemia or thrombocytopenia suggests bone marrow pathology rather than reactive leukocytosis, as indicated by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4

Direct all management at the underlying cervical cancer according to NCCN guidelines, which includes standard staging workup and definitive cancer treatment, without modification for leukocytosis alone, as recommended by the Journal of the National Comprehensive Cancer Network : JNCCN 1, 2, 5
Do not treat the reactive leukocytosis with G-CSF or other growth factors, as these are reserved for neutropenia, not leukocytosis, according to Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4

Start hydroxyurea 50-60 mg/kg/day to achieve 50% WBC reduction within 1-2 weeks if hyperleukocytosis persists and is causing symptoms, as suggested by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 3, 6
Consider leukapheresis only if symptomatic leukostasis with organ compromise is present, and do not delay definitive cancer therapy while performing leukapheresis, as indicated by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4
Initiate aggressive intravenous hydration at 2.5-3 liters/m²/day immediately for WBC ≥100,000/μL, and monitor for tumor lysis syndrome, as suggested by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 3, 6
Do not attribute all leukocytosis to cancer, and systematically rule out infection, especially in immunocompromised patients or those with HIV, as recommended by the Journal of the National Comprehensive Cancer Network : JNCCN 5
Do not ignore concurrent cytopenias, as anemia or thrombocytopenia with leukocytosis suggests bone marrow involvement requiring different evaluation, according to Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4